2025
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer, Usman Shah MD and Sam Skariah MD (Article)
Benchmarking clinical reasoning and accuracy of large language models on breast oncology multiple-choice questions, Ritu Sidgal and Trevor Lin (Article)
Solid Organ Malignancies: Management of the Cancer patient with Chest Pain, Shortness of Breath, and QTc Prolongation, Savitri Skandan MD and Nadeem V. Ahmad MD (Presentation)
Beyond Aesthetics: Cold Cap Hair Preservation Correlates with Lower Chemotherapy Symptom Burden in Patients with Breast Cancer, Talar Telvizian MD (Article)
Primary splenic angiosarcoma presenting as thrombocytopenia., Talar Telvizian MD, Alexander C May, Obed Agyei, and Erik Zeger (Article)
Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective., Amir Toor MD, Morgan Horton, Haniya Khalid, Elizabeth Krieger, Tsung-Po Lai, Stephen R Spellman, John E Levine, Wael Saber, Abraham Aviv, Valerie Stewart, and Shahinaz M Gadalla (Article)
Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective., Amir Toor MD; Morgan M. Horton BSN, RN, CCRC; Haniya Khalid; Elizabeth Krieger; Tsung-Po Lai; Stephen R Spellman; John E Levine; Wael Saber; Valerie Stewart; and Shahinaz M Gadalla (Article)
A plain language summary looking at how well larotrectinib works and how safe it is for people with TRK fusion-positive thyroid cancer., Steven G Waguespack, Maria E Cabanillas, Vadim Bernard-Gauthier, Nandini Assar, Gary Bloom, Rebecca Esparza, and Marcia S Brose (Article)
PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature., Shuanzeng Wei, Arthur S Patchefsky, Jianming Pei, Scot A Brown, Atrayee Basu Mallick, Zixuan Wang, and Wei Jiang (Article)
A smart pill bottle and text messaging intervention for promoting medication adherence in patients with chronic myeloid leukemia: a pilot study of txt4 TKI., Kuang-Yi Wen, Neil Palmisiano, Rita Smith, Rachel Slamon, Gina Keiffer, Christian Fidler, Margaret Kasner, and Lindsay Wilde (Article)
Targeting CD47: many misses; hopeful for a hit., Lindsay Wilde and Margaret Kasner (Article)
Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myeloma, Zachary Wolfe MD (Article)
Ask the Experts: Community Engagement Studios to Inform Research on Cannabis Use in Cancer Symptom Management, B Worster (Article)
Comparing the Effectiveness of Cannabis to Treat Sleep Impairments between Those With and Without Sleep Disorders, B Worster (Article)
The Intersection of Cannabis Use and ADHD: Patterns, Correlates, and Clinical Implications, B Worster (Article)
Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR., Kitsada Wudhikarn; Megan M Herr; Min Chen; Michael J Martens; John H Baird; Lohith Gowda; Hemalatha G Rangarajan; Muhammad Bilal Abid; Mohamed A Kharfan-Dabaja; Kristen M Williams; Siddhartha Ganguly; Jo-Anne H Young; Akshay Sharma; Giancarlo Fatobene; Tania Jain; Christopher G Kanakry; Dipenkumar Modi; Natalie S Grover; Baheyeldin Salem; Marjorie Vieira Batista; Paschalis Vergidis; Dwight E Yin; Amer M Beitinjaneh; Amar H Kelkar; Taiga Nishihori; Jennifer Holter-Chakrabarty; Usama Gergis MD, MBA; Melody Smith; Zeinab El Boghdadly; Christopher E Dandoy; Hemant S Murthy; Anna R Huppler; Miguel-Angel Perales; Roy F Chemaly; Joshua A Hill; Marcie Riches; and Jeff J Auletta (Article)
2024
Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers., Rebecca L Ashare, Brooke Worster, Shannon M Nugent, Danielle M Smith, Benjamin J Morasco, Amy E Leader, Amy A Case, and Salimah H Meghani (Article)
Association between TP53 gain of function and loss of function mutational subgroups and survival in pancreatic adenocarcinoma., A Basu Mallick (Article)
Characterizing patterns of mTORC1 activation across sarcoma subtypes using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database, A Basu Mallick (Article)
Phase 2A trial of Ad5.F35-GUCY2C-PADRE vaccine for recurrence prevention in gastrointestinal (GI) adenocarcinomas post definitive surgery and adjuvant therapies., A Basu Mallick (Article)
Improving the understanding of integrative oncology approaches among hospitalized patients with cancer, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide – a Single Center Experience, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Music Therapy for Pain Management for People With Advanced Cancer: A Randomized Controlled Trial., Joke Bradt, Amy Leader, Brooke Worster, Kate Myers-Coffman, Karolina Bryl, Jacelyn Biondo, Brigette Schneible, Carrie Cottone, Preethi Selvan, and Fengqing Zhang (Article)
Long-term efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion thyroid carcinoma (TC)., M Brose (Article)
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy., Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, and Martin Schlumberger (Article)
A phase I clinical trial evaluating exarafenib, a selective pan-RAF inhibitor in combination with binimetinib in NRAS-mutant (NRASMut) melanoma (Mel) & BRAF-altered solid tumors, M S. Brose (Article)
First-in-human, phase 1 study of a selective RET inhibitor, LOXO-260, in patients with RET inhibitor refractory, RET-altered cancers, M S. Brose (Article)
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study., Jaume Capdevila, Jolanta Krajewska, Jorge Hernando, Bruce Robinson, Steven I Sherman, Barbara Jarzab, Chia-Chi Lin, Fernanda Vaisman, Ana O Hoff, Erika Hitre, Daniel W Bowles, Denise Williamson, Roman Levytskyy, Jennifer Oliver, Bhumsuk Keam, and Marcia S Brose (Article)
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial., T K Choueiri, T M Kuzel, S S Tykodi, E Verzoni, H Kluger, Suresh G. Nair MD, R Perets, S George, H Gurney, R K Pachynski, E Folefac, V Castonguay, C-H Lee, U Vaishampayan, W H Miller, P Bhagavatheeswaran, Y Wang, S Gupta, H DeSilva, C-W Lee, B Escudier, and R J Motzer (Article)
A Case of μ Heavy and λ Light Chain Amyloidosis in a Patient With Bi-Clonal (IgM κ and λ) Gammopathy Treated With Daratumumab., Armaan Dhaliwal MD, Ashish Tripathi, and Soumiya Ravi (Article)
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers., Gary L Ellison, Kathy J Helzlsouer, Sonia M Rosenfield, Yun Kim, Rebecca L Ashare, Anne H Blaes, Jennifer Cullen, Neal Doran, Jon O Ebbert, Kathleen M Egan, Jaimee L Heffner, Richard T Lee, Erin A McClure, Corinne McDaniels-Davidson, Salimah H Meghani, Polly A Newcomb, Shannon Nugent, Nicholas Hernandez-Ortega, Talya Salz, Denise C Vidot, Brooke Worster, and Dylan M Zylla (Article)
Cabozantinib tolerability in metastatic renal cell carcinoma: A meta-analysis, Hafsa Farooq MD (Article)
SILENT STRANGULATION: THE UNSEEN THREAT OF THYROID ENLARGEMENT, Boula Gattas (Article)
Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Subanalysis of Black Patients (pts), Usama Gergis MD, MBA (Article)
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer., Andrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, Marcia S Brose, Lori J Wirth, Taofeek Owonikoko, Svetlana Babajanyan, and Francis P Worden (Article)
"Addressing barriers to digital health readiness among a Latino population"., Karla Martin González, Alexzandra T Gentsch, Chelsea Torres, Elias Borne, Josefina Hendry, Lianette Pappaterra, Maryann Salib, Brooke Worster, Steven Gravier-Leon, and Kristin L Rising (Article)
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study., Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Dianna S Howard, Uroosa Ibrahim, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir Toor MD, Stephanie Waldvogel, Lee M Greenberger, Jeffery J Auletta, Mary M Horowitz, Marcie L Riches, and Miguel-Angel Perales (Article)
Rituximab-Associated Liver Toxicity Without Known Viral Reactivation., Taha Huda; Fawaz Hussain; Hariharasudan Mani MD; Shereen M F Gheith MD, PhD; and Savitri Skandan MD (Article)
Oral Decitabine-Cedazuridine: Adverse Effects and Tolerability in a Real-World, Multicenter Retrospective Study, M Kasner (Article)
Radiate Equity: The Inclusion of Radiation Oncology and Other Specialities in Lymphoma Collaborative Groups, M Kasner (Article)
Real-world analysis of HyperCVAD + TKI for untreated Ph+ ALL., M Kasner (Article)
Real-world retrospective study of oral versus intravenous HMA-induced toxicity in MDS and AML treatment, M Kasner (Article)
North American Cancer Center Clinical Research Capacity and Benchmarking in the Postpandemic Era., Margaret Kasner, Angela H Fritsche, Man Chong Leong, Kendra Cameron, Carrie B Lee, Tara L Lin, Ji-Hyun Lee, Frances Brogan, Matthew R Kovak, Hailey Honeycutt, Kate Shaw, and Thomas J George (Article)
Perspectives from patients with chronic lung disease on a telehealth-facilitated integrated palliative care model: a qualitative content analysis study., Jeannette Kates, Carrie Tompkins Stricker, Kristin L Rising, Alexzandra T Gentsch, Ellen Solomon, Victoria Powers, Venise J Salcedo, and Brooke Worster (Article)
Evaluation of Patients Admitted to the Hospital with Sepsis, Febrile Neutropenia, or Pneumonia Following Administration of Chemotherapy, Abigail Kennedy; Savitri Skandan MD; Dennis Sopka MD; and Melissa Kratz RN, MSN, AOCN (Poster)
Process Improvements for the Treatment of Iron Deficiency Anemia in Pregnancy, Iris Kong MD, Natalie Chlus MD, and Bradley Lash MD (Poster)
Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6, Bradley Lash (Article)
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146., Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, and Mark J Messing (Article)
A Rare Case of Duodenal Adenocarcinoma With Brain Metastasis., Hariharasudan Mani MD, Alisha Hossain DO, Elsie S. Lee MD, and Muhammad A. Rizvi MD (Article)
Retrospective Study of Unresectable Stage III or Stage IV Melanoma Patients Refractory to Immune Check Point and BRAF/MEK Inhibitors, Treated with Triplet Therapy: A Single Institution Experience., Hariharasudan Mani MD; Suresh G. Nair MD; Timothy Johnson MD; Darshan Lal MD; Zeeshan Hafeez MD; Hope Kincaid MPH, CPH; Alyson McIntosh MD; and Aaron U. Blackham MD (Presentation)
5-FU Mediated Coronary Vasospasm Leading to Stress Cardiomyopathy, Merissa Misiura MD, Amogh M. Joshi DO, Noah Dessalegn MD, Muhammad Aamir MD, Nicholas Lamparella DO, and Ronak Patel MD (Poster)
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial., Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G. Nair MD, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, and Viktor Grünwald (Article)
A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma, Suresh G. Nair MD (Article)
Smoking cessation counselling patterns in cancer patients - survey of Lebanese physicians., Jad Najdi, Mariana El Hawa, Adnan El-Achkar, Nour Naji, Talar Telvizian MD, Maya Romani, Albert El Hajj, and Deborah Mukherji (Article)
Evaluating Lehigh Valley Health Network's Stage 1A Lung Cancer Care in Concordance with National Guidelines, Katie O'Connor; Melissa Kratz RN, MSN, AOCN; Savitri Skandan MD; and Dennis Sopka MD (Poster)
S3256 A Rare Case of Primary Germinoma of the Spinal Cord Causing Progressive Dysphagia, Rachel Patel DO, Amanda Jacubowsky DO, Nicholas Lamparella DO, and Paul Palyca MD (Article)
An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county., Andrew M Peseski, Sargam Kapoor, Maragatha Kuchibhatla, Alys Adamski, Karon Abe, Michele G Beckman, Nimia L Reyes, Lisa C Richardson, Ibrahim Saber, Ryan Schulteis, Bhavana Pendurthi Singh MD, Andrea Sitlinger, Elizabeth H Thames, and Thomas L Ortel (Article)
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma., Spencer J Poiset, Sophia Shah, Louis Cappelli, Pramila Anné, Karen E Mooney, Maria Werner-Wasik, Talya S Laufer, James A Posey, Daniel Lin, Atrayee Basu Mallick, Harish Lavu, Babar Bashir, Charles J Yeo, and Adam C Mueller (Article)
Intravascular large B-cell lymphoma masquerading as stroke successfully treated with R-Hyper-CVAD., Christopher Popiolek, Kanchan Gupta, Mallorie L. Huff, and Ranju Gupta MD (Article)
Osimertinib-Induced Myositis in a Patient With Metastatic Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation., Aatma Ram MD, Chun Siu, Abir Mukherjee MD, and Ranju Gupta MD (Article)
A Multi-Institution Phase 2, Single-Arm, Non-Inferiority Study of Limited-Duration Teclistamab for Relapsed and Refractory Multiple Myeloma (LimiTec), B Razzi, S Girgis, L Finnaca, S Le, S Whittington, G Mellgard, C B. Grady, Zachary Wolfe MD, A F. Binder, R Chakraborty, C Strouse, H Shaikh, S Kapur, S Susanibar-Adaniya, A Waxman, D T. Vogl, A D. Cohen, E A. Stadtmauer, W-T Hwang, and A L. Garfall (Article)
Assessing tolerability with the Functional Assessment of Cancer Therapy item GP5: psychometric evidence from LIBRETTO-531, a phase 3 trial of selpercatinib in medullary thyroid cancer., Antoine Regnault, Laurine Bunod, Angely Loubert, Marcia S Brose, Lisa M Hess, Patricia Maeda, Yan Lin, Rebecca M Speck, Adrienne M Gilligan, and Nalin Payakachat (Article)
Development and Preliminary Validation of a Screener for Digital Health Readiness., Kristin L Rising, Amanda Guth, Alexzandra T Gentsch, Karla Martin Gonzalez, Richard Hass, Lindsey Shughart, Serena Gelfer, Megan McVane, Brooke Worster, and Amy E Leader (Article)
Gastric Neuroendocrine Tumors and Pernicious Anemia: A Case Report and Literature Review., James J Rudolph, Obed Agyei, Talar Telvizian MD, and Arezoo Ghaneie (Article)
Attention Deficit Hyperactivity Disorder, Cannabis Use, and the Endocannabinoid System: A Scoping Review., Jennie E Ryan, Mitchell Fruchtman, Andrea Sparr-Jaswa, Amy Knehans, and Brooke Worster (Article)
Prenatal Polysubstance Use and Attention-Deficit/Hyperactivity Disorder (ADHD)., Jennie E Ryan, Sean Esteban McCabe, Timothy E Wilens, Alexander Weigard, Brooke Worster, and Philip Veliz (Article)
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study., James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak Shah, Matthew Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Debra A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G. Nair MD, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, and Michael A Postow (Article)
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study., Vivek Subbiah, Mimi I Hu, Aaron S Mansfield, Matthew H Taylor, Martin Schuler, Viola W Zhu, Julien Hadoux, Giuseppe Curigliano, Lori Wirth, Justin F Gainor, Guzman Alonso, Douglas Adkins, Yann Godbert, Myung-Ju Ahn, Philippe A Cassier, Byoung Chul Cho, Chia-Chi Lin, Alena Zalutskaya, Teresa Barata, Peter Trask, Astrid Scalori, Walter Bordogna, Sebastian Heinzmann, and Marcia S Brose (Article)
Biomedical text readability after hypernym substitution with fine-tuned large language models., Karl Swanson, Shuhan He, Josh Calvano, David Chen, Talar Telvizian MD, Lawrence Jiang, Paul Chong, Jacob Schwell, Gin Mak, and Jarone Lee (Article)
The Mutational Landscape of Anaplastic Thyroid Cancer: Rationale for Targeted Therapies?, Talar Telvizian MD (Article)
Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study, Amir Toor MD (Article)
Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year., Matthew P Wallingford, Erin L Kelly, Allison Herens, Daniel Hanna, Emily Hajjar, and Brooke Worster (Article)
Durability of Response With Selpercatinib in Patients With, Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Ben Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel S W Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander Drilon, and Philippe A Cassier (Article)
Comparing the Effectiveness of Cannabis to Treat Sleep Impairments Between Those with and Without Sleep Disorders, B Worster (Article)
Optimizing influenza vaccination among oncology patients through quality improvement cycles, B Worster (Article)
Toward reducing racialized pain care disparities: Approaching cannabis research and access through the lens of equity and inclusion., Brooke Worster, Salimah H Meghani, Amy E Leader, Shannon M Nugent, Katie Fitzgerald Jones, Katherine A Yeager, Kevin Liou, and Rebecca L Ashare (Article)
The impact of outpatient supportive oncology on cancer care cost and utilization., Brooke Worster, Yifan Zhu, Gregory Garber, Sawyer Kieffer, and Aaron Smith-McLallen (Article)
Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma, Amber Zukas CRNP (Article)
TAKING A BITE OUT OF HOSPITAL ADMISSION DAYS USING A TEAM APPROACH TO MANAGING PATIENTS AT RISK FOR TREATMENT RELATED TOXICITIES, Amber Zukas CRNP (Article)
2023
Social Determinants of Health Associated with How Cannabis is Obtained and Used in Patients with Cancer Receiving Care at a Cancer Treatment Center in Pennsylvania., Rebecca L Ashare, Esther Turay, Brooke Worster, Reagan R Wetherill, L Cinnamon Bidwell, Abigail Doucette, and Salimah H Meghani (Article)
Early Outcomes of MR-Guided SBRT for Patients with Recurrent Pancreatic Adenocarcinoma, A Basu Mallick (Article)
Sonoporation for disrupting the pancreatic cancer microenvironment to enhance chemotherapy delivery and improve outcomes., A Basu Mallick (Article)
Open label single arm study to assess the implementation of home based daratumumab administration in patients being treated for multiple myeloma., Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC), M Brose (Article)
Important Considerations for Real-World Analysis of Neurotrophic Tyrosine Receptor Kinase Fusion Cancer and Tropomyosin Receptor Kinase Inhibitors., Marcia S Brose, David S Hong, and Alexander Drilon (Article)
Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC-311 by BRAF status, M S. Brose (Article)
Randomized phase III study of selpercatinib versus cabozantinib or vandetanib in advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer, M S. Brose (Article)
Physicians' Perspectives on Their Training for and Role Within Pennsylvania's Medical Cannabis Program., Khanh Bui, Brooke Worster, Jennie Ryan, Swechhya Pant, and Erin L Kelly (Article)
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit., Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J Edenfield, Elizabeth Claire Dees, Adedayo A Onitilo, Gary L Buchschacher, Alan M Miller, Benjamin M Parsons, Timothy R Wassenaar, Jennifer M Suga, Robert D Siegel, William Irvin, Suresh G. Nair MD, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory A Masters, Sachdev Thomas, Malek M Safa, Daniel M Anderson, Jonathan Mowers, Anna C Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D Bryan Johnson, Daniel R Rhodes, and Scott A Tomlins (Article)
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma., Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, A Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G. Nair MD, Angelo A. Baccala MD, Paul Palyca MD, Bradley Lash MD, Muhammad A. Rizvi MD, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopa Iyer, Jonathan E Rosenberg, Min Y Teo, and Dean F Bajorin (Article)
Feasibility and Cost of Telehealth Head and Neck Cancer Survivorship Care: A Systematic Review., Emma De Ravin, Maria Armache, Frank Campbell, Kristin L Rising, Brooke Worster, Nathan R Handley, Christopher E Fundakowski, David M Cognetti, and Leila J Mady (Article)
Comparison of outcomes of Clostridium difficile infection in autologous stem cell transplant recipients compared to allogenic stem cell transplant recipients., Armaan Dhaliwal MD (Article)
Effect on hospital outcomes of hematopoietic stem cell transplant recipients with Clostridium difficile infection., Armaan Dhaliwal MD (Article)
Effect on in-hospital outcomes of patients with hepatocellular carcinoma on aspirin., Armaan Dhaliwal MD (Article)
Genomic profiling between Hispanic Americans (HA) and non-Hispanic (NHW) with advanced prostate cancer: A retrospective analysis of tissue, liquid, and germline testing., Armaan Dhaliwal MD (Article)